Regenerative medicine for spinal cord injury: focus on stem cells and biomaterials

References

• Singh A, Tetreault L, Kalsi-Ryan S, et al. Global Prevalence and incidence of traumatic spinal cord injury. Clin Epidemiol. 2014;6:309–331.
   PubMed Web of Science ®Google Scholar
• Anderson CR, Ashwell KW, Collewijn H, et al. the spinal cord: a christopher and dana reeve foundation text and atlas. Spinal Cord. Elsevier. 2009.
   Google Scholar
• Silva NA, Sousa N, Reis RL, et al. From basics to clinical: A comprehensive review on spinal cord injury. Prog Neurobiol. 2014;114:25–57.
   PubMed Web of Science ®Google Scholar
• Breslin K, Agrawal D. The use of methylprednisolone in acute spinal cord injury: A review of the evidence, controversies, and recommendations. Pediatr Emerg Care. 2012;28(11):1238–1245.
   PubMed Web of Science ®Google Scholar
• Hurlbert RJ, Hadley MN, Walters BC, et al. Pharmacological therapy for acute spinal cord injury. Neurosurgery. 2013;72(suppl_3):93–105.
   PubMedGoogle Scholar
• Carreon LY, Dimar JR. Early versus late stabilization of spine injuries: A systematic review. Spine (Phila. Pa. 1976). 2011(36):727–733.
   Google Scholar
• Gómara-Toldrà N, Sliwinski M, Dijkers MP. Physical therapy after spinal cord injury: A systematic review of treatments focused on participation. J Spinal Cord Med. 2014;37(4):371–379.
   PubMed Web of Science ®Google Scholar
• Kwon BK, Okon EB, Plunet W, et al. A systematic review of directly applied biologic therapies for acute spinal cord injury. J Neurotrauma. 2011;28(8):1589–1610.
   PubMed Web of Science ®Google Scholar
• Rossi F, Perale G, Papa S, et al. Current options for drug delivery to the spinal cord. Expert Opin Drug Deliv. 2013;10:385–396.
   PubMed Web of Science ®Google Scholar
• Huston T, Gassaway J, Wilson C, et al. The SCIRehab project: treatment time spent in SCI rehabilitation. Psychology treatment time during inpatient spinal cord injury rehabilitation. J Spinal Cord Med. 2011;34:196–204.
   PubMed Web of Science ®Google Scholar
• Vismara I, Papa S, Rossi F, et al. Current options for cell therapy in spinal cord injury. Trends Mol Med. 2017;23:831–849.
   PubMed Web of Science ®Google Scholar
• Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, et al. A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma. 2011;28:1611–1682.
   PubMed Web of Science ®Google Scholar
• Shoichet MS. Polymer scaffolds for biomaterials applications. Macromolecules. 2010;43:581–591.
   Web of Science ®Google Scholar
• Caron I, Rossi F, Papa S, et al. A new three dimensional biomimetic hydrogel to deliver factors secreted by human mesenchymal stem cells in spinal cord injury. Biomaterials. 2016;75:135–147.
   PubMed Web of Science ®Google Scholar
• Dumont RJ, Verma S, Okonkwo DO, et al. Acute spinal cord injury, part II: contemporary pharmacotherapy. Clin Neuropharmacol. 2001;24:265–279.
   PubMed Web of Science ®Google Scholar
• Priestley JV, Michael-Titus AT, Tetzlaff W. Limiting spinal cord injury by pharmacological intervention. 1st ed. Handb. Clin Neurol 2012. Vol. 109. pp. 463-484. Elsevier B.V.
   PubMedGoogle Scholar
• Ronsyn MW, Berneman ZN, Van Tendeloo VFI, et al. Can cell therapy heal a spinal cord injury? Spinal Cord. 2008;46(8):532–539.
   PubMed Web of Science ®Google Scholar
• Roy RR, Harkema SJ, Edgerton VR. Basic concepts of activity-based interventions for improved recovery of motor function after spinal cord injury. Arch Phys Med Rehabil. 2012;93:1487–1497.
   PubMed Web of Science ®Google Scholar
• Petruska JC, Ichiyama RM, Jindrich DL, et al. Changes in motoneuron properties and synaptic inputs related to step training after spinal cord transection in rats. J Neurosci. 2007;27:4460–4471.
   PubMed Web of Science ®Google Scholar
• Tator CH. Experimental and clinical studies of the pathophysiology and management of acute spinal cord injury. J Spinal Cord Med. 1996;19:206–214.
   PubMedGoogle Scholar
• Bareyre FM, Schwab ME. Inflammation, degeneration and regeneration in the injured spinal cord: insights from DNA microarrays. Trends Neurosci. 2003;26:555–563.
   PubMed Web of Science ®Google Scholar
• Donnelly DJ, Popovich PG. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Experimental Neurology. 2008;209(2):378–388.
   PubMed Web of Science ®Google Scholar
• Bethea JR, Dietrich WD. Targeting the host inflammatory response in traumatic spinal cord injury. Curr Opin Neurol. 2002;15:355–360.
   PubMed Web of Science ®Google Scholar
• Bruce JH, Norenberg MD, Kraydieh S, et al. Schwannosis: role of gliosis and proteoglycan in human spinal cord injury. J Neurotrauma. 2000;17:781–788.
   Web of Science ®Google Scholar
• Azari F, Mathias L, Ozturk E, et al. Mesenchymal stem cells for treatment of CNS injury. Curr Neuropharmacol. 2010;8:316–323.
   PubMed Web of Science ®Google Scholar
• Phinney D, Plasticity II. Therapeutic potential of mesenchymal stem cells in the nervous system. Curr Pharm Des. 2005;11:1255–1265.
   PubMed Web of Science ®Google Scholar
• Lu -L-L, Liu Y-J, Yang S-G, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica. 2006;91:1017–1028.
   PubMed Web of Science ®Google Scholar
• Dasari VR. Mesenchymal stem cells in the treatment of spinal cord injuries: A review. World J Stem Cells. 2014;6:120.
   PubMedGoogle Scholar
• Volkman R, Offen D. Concise review: mesenchymal stem cells in neurodegenerative diseases. Stem Cells. 2017;35(8):1867–1880
   PubMed Web of Science ®Google Scholar
• Kozorovitskiy Y, Gould E. Stem cell fusion in the brain. Nature Cell Biology. 2003;5(11):952–954.
   PubMed Web of Science ®Google Scholar
• Matsushita T, Lankford KL, Arroyo EJ, et al. Diffuse and persistent blood-spinal cord barrier disruption after contusive spinal cord injury rapidly recovers following intravenous infusion of bone marrow mesenchymal stem cells. Exp Neurol. 2015;267:152–164.
   PubMed Web of Science ®Google Scholar
• Morita T, Sasaki M, Kataoka-Sasaki Y, et al. Intravenous infusion of mesenchymal stem cells promotes functional recovery in a model of chronic spinal cord injury. Neuroscience. 2016;335:221–231.
   PubMed Web of Science ®Google Scholar
• Osaka M, Honmou O, Murakami T, et al. Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome. Brain Res. 2010;1343:226–235.
   PubMed Web of Science ®Google Scholar
• Zhang M, Guo R, Shi S, et al. Baculovirus vector-mediated transfer of sodium iodide symporter and plasminogen kringle 5 genes for tumor radioiodide therapy. PLoS One. 2014;9:e92326.
   PubMed Web of Science ®Google Scholar
• Neirinckx V, Cantinieaux D, Coste C, et al. Concise review: spinal cord injuries: how could adult mesenchymal and neural crest stem cells take up the challenge. Stem Cells. 2014;32:829–843.
   PubMed Web of Science ®Google Scholar
• Wang LJ, Zhang RP, Li JD. Transplantation of neurotrophin-3-expressing bone mesenchymal stem cells improves recovery in a rat model of spinal cord injury. Acta Neurochir (Wien). 2014;156:1409–1418.
   PubMed Web of Science ®Google Scholar
• Dai G, Liu X, Zhang Z, et al. Transplantation of autologous bone marrow mesenchymal stem cells in the treatment of complete and chronic cervical spinal cord injury. Brain Res. 2013;1533:73–79.
   PubMed Web of Science ®Google Scholar
• El-Kheir WA, Gabr H, Awad MR, et al. Autologous bone marrow-derived cell therapy combined with physical therapy induces functional improvement in chronic spinal cord injury patients. Cell Transplant. 2014;23:729–745.
   PubMed Web of Science ®Google Scholar
• Geffner LF, Santacruz P, Izurieta M, et al. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant. 2008;17:1277–1293.
   PubMed Web of Science ®Google Scholar
• Karamouzian S, Nematollahi-Mahani SN, Nakhaee N, et al. Clinical safety and primary efficacy of bone marrow mesenchymal cell transplantation in subacute spinal cord injured patients. Clin Neurol Neurosurg. 2012;114:935–939.
   PubMed Web of Science ®Google Scholar
• Mendonça MVP, Larocca TF, Souza BSDF, et al. Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury. Stem Cell Res Ther. 2014;5:1–11.
   PubMed Web of Science ®Google Scholar
• Park JH, Kim DY, Sung IY, et al. Long-term results of spinal cord injury therapy using mesenchymal stem cells derived from bone marrow in humans. Neurosurgery. 2012;70:1238–1247.
   PubMed Web of Science ®Google Scholar
• Vaquero J, Zurita M, Rico MA, et al. An approach to personalized cell therapy in chronic complete paraplegia: the Puerta de Hierro phase I/II clinical trial. Cytotherap. 2016;18:1025–1036.
   PubMed Web of Science ®Google Scholar
• Ryan JM, Barry FP, Murphy JM, et al. Mesenchymal stem cells avoid allogeneic rejection. J Inflamm. 2005;2:1–11.
   Google Scholar
• Schira J, Gasis M, Estrada V, et al. Significant clinical, neuropathological and behavioural recovery from acute spinal cord trauma by transplantation of a well-defined somatic stem cell from human umbilical cord blood. Brain. 2012;135:431–446.
   PubMed Web of Science ®Google Scholar
• Chua SJ, Bielecki R, Yamanaka N, et al. The effect of umbilical cord blood cells on outcomes after experimental traumatic spinal cord injury. Spine (Phila. Pa. 1976). 2010(35):1520–1526
   Google Scholar
• Dasari VR, Veeravalli KK, Tsung AJ, et al. Neuronal apoptosis is inhibited by cord blood stem cells after spinal cord injury. Journal of Neurotrauma. 2009;26(11):2057–2069.
   PubMed Web of Science ®Google Scholar
• Kao CH, Chen SH, Chio CC, et al. Human umbilical cord blood-derived CD34+ cells may attenuate spinal cord injury by stimulating vascular endothelial and neurotrophic factors. Shock. 2008;29:49–55.
   PubMed Web of Science ®Google Scholar
• Kang KS, Kim SW, Oh YH, et al. A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: A case study. Cytotherapy. 2005;7:368–373.
   PubMed Web of Science ®Google Scholar
• Zhu H, Poon W, Liu Y, et al. Phase I–II clinical trial assessing safety and efficacy of umbilical cord blood mononuclear cell transplant therapy of chronic complete spinal cord injury. Cell Transplant. 2016;25:1925–1943.
   PubMed Web of Science ®Google Scholar
• Kim EY, Lee KB, Kim MK. The potential of mesenchymal stem cells derived from amniotic membrane and amniotic fluid for neuronal regenerative therapy. BMB Rep. 2014;47:135–140.
   PubMed Web of Science ®Google Scholar
• Bottai D, Scesa G, Cigognini D, et al. Third trimester NG2-positive amniotic fluid cells are effective in improving repair in spinal cord injury. Exp Neurol. 2014;254:121–133.
   PubMed Web of Science ®Google Scholar
• Gao S, Ding J, Xiao HJ, et al. Anti-inflammatory and anti-apoptotic effect of combined treatment with methylprednisolone and amniotic membrane mesenchymal stem cells after spinal cord injury in rats. Neurochem Res. 2014;39:1544–1552.
   PubMed Web of Science ®Google Scholar
• Sankar V, Muthusamy R. Role of human amniotic epithelial cell transplantation in spinal cord injury repair research. Neuroscience. 2003;118:11–17.
   PubMed Web of Science ®Google Scholar
• Ohta Y, Takenaga M, Tokura Y, et al. Mature adipocyte-derived cells, dedifferentiated fat cells (DFAT), promoted functional recovery from spinal cord injury-induced motor dysfunction in rats. Cell Transplant. 2008;17:877–886.
   PubMed Web of Science ®Google Scholar
• Kim YT, Jung JH, Stewart LC, et al. Complete genome sequence of the hyperthermophilic methanogen Methanocaldococcus bathoardescens JH146T isolated from the basalt subseafloor. Mar Genomics. 2015;24:229–230.
   PubMed Web of Science ®Google Scholar
• Kolar MK, Kingham PJ, Novikova LN, et al. The therapeutic effects of human adipose-derived stem cells in a rat cervical spinal cord injury model. Stem Cells Dev. 2014;23(14):1659–1674.
   PubMed Web of Science ®Google Scholar
• Menezes K, Nascimento MA, Gonçalves JP, et al. Human mesenchymal cells from adipose tissue deposit laminin and promote regeneration of injured spinal cord in rats. PLoS One. 2014;9:e96020.
   PubMedGoogle Scholar
• Kang SK, Yeo JE, Kang KS, et al. Cytoplasmic extracts from adipose tissue stromal cells alleviates secondary damage by modulating apoptosis and promotes functional recovery following spinal cord injury. Brain Pathol. 2007;17(3):263–275.
   PubMed Web of Science ®Google Scholar
• Kokai LE, Marra K, Rubin JP. Adipose stem cells: biology and clinical applications for tissue repair and regeneration. Transl Res. 2014;163:399–408.
   PubMed Web of Science ®Google Scholar
• Mukhamedshina YO, Akhmetzyanova ER, Kostennikov AA, et al. Adipose-derived mesenchymal stem cell application combined with fibrin matrix promotes structural and functional recovery following spinal cord injury in rats. Front Pharmacol. 2018;9:1–13.
   PubMed Web of Science ®Google Scholar
• Aras Y, Sabanci PA, Kabatas S, et al. The effects of adipose tissue-derived mesenchymal stem cell transplantation during the acute and subacute phases following spinal cord injury. Turk Neurosurg. 2016;26(1):127–139.
   PubMed Web of Science ®Google Scholar
• Kim Y, Lee SH, Kim WH, et al. Transplantation of adipose derived mesenchymal stem cells for acute thoracolumbar disc disease with no deep pain perception in dogs. J Vet Sci. 2016;17:123–126.
   Google Scholar
• Zhou J, Lu P, Ren H, et al. 17Β-estradiol protects human eyelid-derived adipose stem cells against cytotoxicity and increases transplanted cell survival in spinal cord injury. J Cell Mol Med. 2014;18(2):326–343.
   PubMed Web of Science ®Google Scholar
• Hyun J, Grova M, Nejadnik H, et al. Enhancing in vivo survival of adipose-derived stromal cells through bcl-2 overexpression using a minicircle vector. Stem Cells Transl Med. 2013;2(9):690–702.
   PubMed Web of Science ®Google Scholar
• Lee SH, Kim Y, Rhew D, et al. Effect of the combination of mesenchymal stromal cells and chondroitinase ABC on chronic spinal cord injury. Cytotherapy. 2015;17(10):1374–1383.
   PubMed Web of Science ®Google Scholar
• Hur JW, Cho TH, Park DH, et al. Intrathecal transplantation of autologous adipose-derived mesenchymal stem cells for treating spinal cord injury: A human trial. J Spinal Cord Med. 2016;39:655–664.
   PubMed Web of Science ®Google Scholar
• Ra JC, Shin IS, Kim SH, et al. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev. 2011;20(8):1297–1308.
   PubMed Web of Science ®Google Scholar
• Thakkar U, Vanikar A, Trivedi H, et al. Infusion of autologous adipose tissue derived neuronal differentiated mesenchymal stem cells and hematopoietic stem cells in post-traumatic paraplegia offers a viable therapeutic approach. Adv Biomed Res. 2016;5:51.
   PubMedGoogle Scholar
• Muheremu A, Peng J, Ao Q. Stem cell based therapies for spinal cord injury. Tissue Cell. 2016;48(4):328–333.
   PubMed Web of Science ®Google Scholar
• Goel A. Stem cell therapy in spinal cord injury: hollow promise or promising science? J Craniovertebral Junction Spine. 2016;7:121–126.
   PubMed Web of Science ®Google Scholar
• Shroff G, Titus JD, Shroff R. A review of the emerging potential therapy for neurological disorders: human embryonic stem cell therapy. Am J Stem Cells. 2017;6:1–12.
   PubMed Web of Science ®Google Scholar
• Shroff G, Gupta R. Human embryonic stem cells in the treatment of patients with spinal cord injury. Ann Neurosci. 2015;22:208–216.
   PubMed Web of Science ®Google Scholar
• Salewski RP, Mitchell RA, Shen C, et al. Transplantation of neural stem cells clonally derived from embryonic stem cells promotes recovery after murine spinal cord injury. Stem Cells Dev. 2015;24(1):36–50.
   PubMed Web of Science ®Google Scholar
• Johnson PJ, Tatara A, Shiu A, et al. Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI. Cell Transplant. 2010;19(1):89–101.
   PubMed Web of Science ®Google Scholar
• All AH, Gharibani P, Gupta S, et al. Early intervention for spinal cord injury with human induced pluripotent stem cells oligodendrocyte progenitors. PLoS One. 2015;10(1):1–27.
   Web of Science ®Google Scholar
• Sun Y, Xu CC, Li J, et al. Transplantation of oligodendrocyte precursor cells improves locomotion deficits in rats with spinal cord irradiation injury. PLoS One. 2013;8:1–9.
   Web of Science ®Google Scholar
• Frantz S. Embryonic stem cell pioneer Geron exits field, cuts losses. Nat Biotechnol. 2012;30:12–13.
   PubMed Web of Science ®Google Scholar
• Emgård M, Piao J, Aineskog H, et al. Neuroprotective effects of human spinal cord-derived neural precursor cells after transplantation to the injured spinal cord. Exp Neurol. 2014;253:138–145.
   PubMed Web of Science ®Google Scholar
• Hawryluk GWJ, Mothe A, Wang J, et al. An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury. Stem Cells Dev. 2012;21:2222–2238.
   PubMed Web of Science ®Google Scholar
• Shroff G. Human embryonic stem cell therapy in chronic spinal cord injury: a retrospective study. Clin Transl Sci. 2016;9:168–175.
   PubMed Web of Science ®Google Scholar
• Katoh H, Yokota K, Fehlings MG. Regeneration of spinal cord connectivity through stem cell transplantation and biomaterial scaffolds. Front Cell Neurosci. 2019;13:1–22.
   PubMed Web of Science ®Google Scholar
• Yokota K, Kobayakawa K, Saito T, et al. Periostin promotes scar formation through the interaction between pericytes and infiltrating monocytes/macrophages after spinal cord injury. Am J Pathol. 2017;187(3):639–653.
   PubMed Web of Science ®Google Scholar
• Khazaei M, Ahuja CS, Fehlings MG. Induced pluripotent stem cells for traumatic spinal cord injury. Front Cell Dev Biol. 2017;4:1–9.
   Web of Science ®Google Scholar
• Yao R, Murtaza M, Velasquez JT, et al. Olfactory ensheathing cells for spinal cord injury: sniffing out the issues. Cell Transplant. 2018;27:879–889.
   PubMed Web of Science ®Google Scholar
• Yang H, He BR, Hao DJ. Biological roles of olfactory ensheathing cells in facilitating neural regeneration: a systematic review. Mol Neurobiol. 2014;51:168–179.
   PubMed Web of Science ®Google Scholar
• Khankan RR, Griffis KG, Haggerty-Skeans JR, et al. Olfactory ensheathing cell transplantation after a complete spinal cord transection mediates neuroprotective and immunomodulatory mechanisms to facilitate regeneration. J Neurosci. 2016;36:6269–6286.
   PubMed Web of Science ®Google Scholar
• Ramón-Cueto A, Muñoz-Quiles C. Clinical application of adult olfactory bulb ensheathing glia for nervous system repair. Exp Neurol. 2011;229:181–194.
   PubMed Web of Science ®Google Scholar
• Ramón-Cueto A, Cordero MI, Santos-Benito FF, et al., Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron. 25(2): 425–435. 2000.
   PubMed Web of Science ®Google Scholar
• Watzlawick R, Rind J, Sena ES, et al. Olfactory ensheathing cell transplantation in experimental spinal cord injury: effect size and reporting bias of 62 experimental treatments: a systematic review and meta-analysis. PLoS Biol. 2016;14(5):1–16.
   Web of Science ®Google Scholar
• Novikova LN, Lobov S, Wiberg M, et al. Efficacy of olfactory ensheathing cells to support regeneration after spinal cord injury is influenced by method of culture preparation. Exp Neurol. 2011;229:132–142.
   PubMed Web of Science ®Google Scholar
• Bunge MB, Wood PM. Realizing the maximum potential of schwann cells to promote recovery from spinal cord injury. 1st ed. Handb. Clin Neurol 2012. Vol 109. pp. 523-540. Elsevier B.V.
   PubMedGoogle Scholar
• Myers SA, Bankston AN, Burke DA, et al. Does the preclinical evidence for functional remyelination following myelinating cell engraftment into the injured spinal cord support progression to clinical trials? Exp. Neurol. 2016;283:560–572.
   Web of Science ®Google Scholar
• Bunge MB. Efficacy of schwann cell transplantation for spinal cord repair is improved with combinatorial strategies. J Physiol. 2016;594:3533–3538.
   PubMed Web of Science ®Google Scholar
• Zhou XH, Ning GZ, Feng SQ, et al. Transplantation of autologous activated schwann cells in the treatment of spinal cord injury: six cases, more than five years of follow-up. Cell Transplant. 2012;21:39–47.
   PubMed Web of Science ®Google Scholar
• Oraee-Yazdani S, Hafizi M, Atashi A, et al. Co-transplantation of autologous bone marrow mesenchymal stem cells and schwann cells through cerebral spinal fluid for the treatment of patients with chronic spinal cord injury: safety and possible outcome. Spinal Cord. 2016;54(2):102–109.
   PubMed Web of Science ®Google Scholar
• Lima C, Escada P, Pratas-Vital J, et al. Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury. Neurorehabil Neural Repair. 2010;24:10–22.
   PubMed Web of Science ®Google Scholar
• Mackay-Sim A, Féron F, Cochrane J, et al. Autologous olfactory ensheathing cell transplantation in human paraplegia: A 3-year clinical trial. Brain. 2008;131(9):2376–2386.
   PubMed Web of Science ®Google Scholar
• Féron F, Perry C, Cochrane J, et al. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain. 2005;128(12):2951–2960.
   PubMed Web of Science ®Google Scholar
• Sabelström H, Stenudd M, Frisén J. Neural stem cells in the adult spinal cord. Exp Neurol. 2014;260:44–49.
   PubMed Web of Science ®Google Scholar
• Kumagai G, Tsoulfas P, Toh S, et al. Genetically modified mesenchymal stem cells (MSCs) promote axonal regeneration and prevent hypersensitivity after spinal cord injury. Exp Neurol. 2013;248:369–380.
   PubMed Web of Science ®Google Scholar
• Perale G, Rossi F, Sundstrom E, et al. Hydrogels in spinal cord injury repair strategies. ACS Chem Neurosci. 2011;2:336–345.
   PubMed Web of Science ®Google Scholar
• Perale G, Rossi F, Santoro M, et al. Multiple drug delivery hydrogel system for spinal cord injury repair strategies. J Control Release. 2012;159:271–280.
   PubMed Web of Science ®Google Scholar
• Gupta P, Vermani K, Garg S. Hydrogels: from controlled release to pH-responsive drug delivery. Drug Discov Today. 2002;7:569–579.
   PubMed Web of Science ®Google Scholar
• Ahmed EM. Hydrogel: preparation, characterization, and applications: A review. J Adv Res. 2015;6:105–121.
   PubMed Web of Science ®Google Scholar
• Culver HR, Clegg JR, Peppas NA. Analyte-responsive hydrogels: intelligent materials for biosensing and drug delivery. Acc Chem Res. 2017;50:170–178.
   PubMed Web of Science ®Google Scholar
• Slaughter BV, Khurshid SS, Fisher OZ, et al. Hydrogels in regenerative medicine. Adv Mater. 2009;21:3307–3329.
   PubMed Web of Science ®Google Scholar
• Mauri E, Rossi F, Sacchetti A. Tunable drug delivery using chemoselective functionalization of hydrogels. Mater Sci Eng C. 2016;61:851–857.
   PubMed Web of Science ®Google Scholar
• Anderson SB, Lin CC, Kuntzler DV, et al. The performance of human mesenchymal stem cells encapsulated in cell-degradable polymer-peptide hydrogels. Biomaterials. 2011;32:3564–3574.
   PubMed Web of Science ®Google Scholar
• Gauthier MA, Gibson MI, Klok HA. Synthesis of functional polymers by post-polymerization modification. Angew Chemie Int Ed. 2009;48:48–58.
   PubMed Web of Science ®Google Scholar
• Rossi F, Ferrari R, Castiglione F, et al. Polymer hydrogel functionalized with biodegradable nanoparticles as composite system for controlled drug delivery. Nanotechnology. 2015;26:015602.
   PubMedGoogle Scholar
• Agbay A, Edgar JM, Robinson M, et al. Biomaterial strategies for delivering stem cells as a treatment for spinal cord injury. Cells Tissues Organs. 2016;202(1–2):42–51.
   PubMed Web of Science ®Google Scholar
• Tavakol S, Saber R, Hoveizi E, et al. chimeric self-assembling nanofiber containing bone marrow homing peptide’s motif induces motor neuron recovery in animal model of chronic spinal cord injury; an in vitro and in vivo investigation. Mol Neurobiol. 2016;53:3298–3308.
   PubMed Web of Science ®Google Scholar
• Ritfeld GJ, Rauck BM, Novosat TL, et al. The effect of a polyurethane-based reverse thermal gel on bone marrow stromal cell transplant survival and spinal cord repair. Biomaterials. 2014;35(6):1924–1931.
   PubMed Web of Science ®Google Scholar
• Onuma-Ukegawa M, Bhatt K, Hirai T, et al. Bone marrow stromal cells combined with a honeycomb collagen sponge facilitate neurite elongation in vitro and neural restoration in the hemisected rat spinal cord. Cell Transplant. 2015;24:1283–1297.
   PubMed Web of Science ®Google Scholar
• Han S, Wang B, Li X, et al. Bone marrow-derived mesenchymal stem cells in three-dimensional culture promote neuronal regeneration by neurotrophic protection and immunomodulation. J Biomed Mater Res A. 2016;104:1759–1769.
   PubMed Web of Science ®Google Scholar
• Günther MI, Weidner N, Müller R, et al. Cell-seeded alginate hydrogel scaffolds promote directed linear axonal regeneration in the injured rat spinal cord. Acta Biomater. 2015;27:140–150.
   PubMed Web of Science ®Google Scholar
• Amr SM, Gouda A, Koptan WT, et al. Bridging defects in chronic spinal cord injury using peripheral nerve grafts combined with a chitosan-laminin scaffold and enhancing regeneration through them by co-transplantation with bone-marrow-derived mesenchymal stem cells: case series of 14 patient. J Spinal Cord Med. 2014;37:54–71.
   PubMed Web of Science ®Google Scholar
• Liu J, Chen J, Liu B, et al. Acellular spinal cord scaffold seeded with mesenchymal stem cells promotes long-distance axon regeneration and functional recovery in spinal cord injured rats. J Neurol Sci. 2013;325:127–136.
   PubMed Web of Science ®Google Scholar
• Park SS, Lee YJ, Lee SH, et al. Functional recovery after spinal cord injury in dogs treated with a combination of matrigel and neural-induced adipose-derived mesenchymal stem cells. Cytotherapy. 2012;14:584–597.
   PubMed Web of Science ®Google Scholar
• Prewitz MC, Seib FP, von Bonin M, et al. Tightly anchored tissue-mimetic matrices as instructive stem cell microenvironments. Nat Methods. 2013;10:788–794.
   PubMed Web of Science ®Google Scholar
• Tukmachev D, Forostyak S, Koci Z, et al. Injectable extracellular matrix hydrogels as scaffolds for spinal cord injury repair. Tissue Eng Part A. 2016;22:306–317.
   PubMed Web of Science ®Google Scholar
• Xie J, Willerth SM, Li X, et al., The differentiation of embryonic stem cells seeded on electrospun nanofibers into neural lineages. Biomaterials. 30(3): 354–362. 2009.
   PubMed Web of Science ®Google Scholar
• Führmann T, Anandakumaran PN, Shoichet MS. Combinatorial therapies after spinal cord injury: how can biomaterials help? Adv Healthc Mater. 2017;6:1–21.
   Web of Science ®Google Scholar
• Shoichet MS. Polymer scaffolds for biomaterials applications. Macromolecules. 2010;43(2):581–591.
   Web of Science ®Google Scholar
• Lovell-Badge R. The future for stem cell research. Nature. 2001;414(6859):88–91.
   PubMed Web of Science ®Google Scholar
• Neves J, Sousa-Victor P, Jasper H. Rejuvenating strategies for stem cell-based therapies in aging. Cell Stem Cell. 2017;20(2):161–175.
   PubMed Web of Science ®Google Scholar
• Dang PN, Dwivedi N, Phillips LM, et al. Controlled dual growth factor delivery from microparticles incorporated within human bone marrow-derived mesenchymal stem cell aggregates for enhanced bone tissue engineering via endochondral ossification. Stem Cells Transl Med. 2016;5:206–217.
   PubMed Web of Science ®Google Scholar
• Papa S, Vismara I, Mariani A, et al. Mesenchymal stem cells encapsulated into biomimetic hydrogel scaffold gradually release CCL2 chemokine in situ preserving cytoarchitecture and promoting functional recovery in spinal cord injury. J Control Release. 2018;278:49–56.
   PubMed Web of Science ®Google Scholar
• Ruppert KA, Nguyen TT, Prabhakara KS, et al. Human mesenchymal stromal cell-derived extracellular vesicles modify microglial response and improve clinical outcomes in experimental spinal cord injury. Sci Rep. 2018;8:1–12.
   PubMed Web of Science ®Google Scholar
• Gimona M, Pachler K, Laner-Plamberger S, et al. Manufacturing of human extracellular vesicle-based therapeutics for clinical use. Int J Mol Sci. 2017:18.
   Web of Science ®Google Scholar
• Liang X, Ding Y, Zhang Y, et al. Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives. Cell Transplant. 2014;23:1045–1059.
   PubMed Web of Science ®Google Scholar
• King NMP, Perrin J. Ethical issues in stem cell research and therapy. Stem Cell Res Ther. 2014;5:2–7.
   PubMed Web of Science ®Google Scholar
• Herberts CA, Kwa MSG, Hermsen HPH. Risk factors in the development of stem cell therapy. J Transl Med. 2011;9:1–14.
   Web of Science ®Google Scholar
• Kramer AS, Harvey AR, Plant GW, et al. Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury. Cell Transplant. 2013;22:571–617.
   PubMed Web of Science ®Google Scholar
• Qu J, Zhang H. Roles of mesenchymal stem cells in spinal cord injury. Stem Cells Int. 2017;2017.
   Web of Science ®Google Scholar
• Li XC, Zhong CF, Bin DG, et al. Efficacy and safety of bone marrow-derived cell transplantation for spinal cord injury: A systematic review and meta-analysis of clinical trials. Clin Transplant. 2015;29:786–795.
   PubMed Web of Science ®Google Scholar
• Jarocha D, Milczarek O, Wedrychowicz A, et al. Continuous improvement after multiple mesenchymal stem cell transplantations in a patient with complete spinal cord injury. Cell Transplant. 2015;24:661–672.
   PubMed Web of Science ®Google Scholar
• Jiang PC, Xiong WP, Wang G, et al. A clinical trial report of autologous bone marrow-derived mesenchymal stem cell transplantation in patients with spinal cord injury. Exp Ther Med. 2013;6:140–146.
   PubMed Web of Science ®Google Scholar
• Hejčl A, Lesný P, Přádný M, et al. Biocompatible hydrogels in spinal cord injury repair. Physiol Res. 2008;57:S121-32.
   PubMed Web of Science ®Google Scholar
• Kwon BK, Sekhon LH, Fehlings MG. Emerging repair, regeneration, and translational research advances for spinal cord injury. Spine Phila Pa. 1976. 2010(35):263–270.
   Google Scholar
• Uludağ H. Grand challenges in biomaterials. Front Bioeng Biotechnol. 2014;2:2–5.
   PubMedGoogle Scholar